高级检索
当前位置: 首页 > 详情页

Traditional Chinese medicine on treating diabetic mellitus erectile dysfunction Protocol for a systematic review and meta-analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China [2]Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Androl, Beijing, Peoples R China [3]Hebei Univ Tradit Chinese Med, Hebei Tradit Chinese Med Hosp, Dept Orthoped, Shijiazhuang, Hebei, Peoples R China [4]Dongzhimen Hosp, Dept Periangiaceae, Beijing, Peoples R China
出处:
ISSN:

关键词: diabetic mellitus erectile dysfunction protocol systematic review traditional Chinese medicine

摘要:
Background: Diabetic mellitus erectile dysfunction (DMED) refers to erectile dysfunction (ED) secondary to diabetes. As people's lifestyle changes and the population ages, the incidence of DMED continues to increase. Many clinical trials have proven that Chinese medicine has a significant effect in the treatment of DMED. In this systematic review, we aim to evaluate the effectiveness and safety of traditional Chinese medicine (TCM) for DMED. Methods: We will search PubMed, Cochrane Library, AMED, EMbase, WorldSciNet; Nature, Science online and China Journal Full-text Database, China Biomedical Literature CD-ROM Database, and related randomized controlled trials included in the China Resources Database. The time is limited from the construction of the library to February, 2019. We will use the criteria provided by Cochrane 5.1.0 for quality assessment and risk assessment of the included studies, and use the Revman 5.3 and Stata13.0 software for meta-analysis of the effectiveness, recurrence rate, and symptom scores of DMED. Ethics and dissemination: This systematic review will evaluate the efficacy and safety of TCM for treating Diabetic mellitus erectile dysfunction. Because all of the data used in this systematic review and meta-analysis has been published, this review does not require ethical approval. Furthermore, all data will be analyzed anonymously during the review process trial.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
JCR分区:
出版当年[2019]版:
Q3 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q2 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China [2]Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Androl, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [2]Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Androl, Beijing, Peoples R China [*1]Department of Andrology, DongzhimenHospital, Dongcheng District, Hai Yun Cang on the 5th ZIP, Beijing 100029,China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:15100 今日访问量:0 总访问量:960 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号